Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of patients having c-met exon 14 skipping mutations

Treatment of patients having c-met exon 14 skipping mutations

US Patent 12215160 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapies with bispecific anti-EGFR/c-met antibodies and third gener2025
Combination therapies with bispecific anti-EGFR/c-met antibodies and third gener2025
EGFR and C-met fibronectin type III domain binding molecules2025
Bispecific EGFR/c-Met antibodies2025
Combination therapies and patient stratification with bispecific anti-EGFR/c-Met2025
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third gener2024
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third gener2024
Proteins comprising HLA-G antigen binding domains and their uses2023
Cyclic dinucleotides as sting agonists2022
Combination therapies and patient stratification with bispecific anti-EGFR/c-Met2022
EGFR and c-Met fibronectin type III domain binding molecules2021
Method of adjuvant cancer treatment2020